- Home
- RNA vs CAAP Comparison
RNA vs CAAP Comparison
Compare RNA & CAAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNA | CAAP |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.2B |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | RNA | CAAP |
|---|---|---|
| Price | $72.39 | $26.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 2 |
| Target Price | ★ $69.26 | $24.60 |
| AVG Volume (30 Days) | ★ 2.1M | 131.8K |
| Earning Date | 02-26-2026 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.09 |
| Revenue | $20,868,000.00 | ★ $1,872,934,000.00 |
| Revenue This Year | $57.30 | $5.19 |
| Revenue Next Year | $28.41 | $7.63 |
| P/E Ratio | ★ N/A | $24.94 |
| Revenue Growth | ★ 106.27 | 25.19 |
| 52 Week Low | $21.51 | $15.01 |
| 52 Week High | $72.61 | $27.76 |
Technical Indicators
Market Signals| Indicator | RNA | CAAP |
|---|---|---|
| Relative Strength Index (RSI) | 73.95 | 60.07 |
| Support Level | $72.04 | $26.30 |
| Resistance Level | $72.47 | $27.76 |
| Average True Range (ATR) | 0.21 | 0.66 |
| MACD | -0.21 | -0.04 |
| Stochastic Oscillator | 63.71 | 58.82 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.